Cue Biopharma, Inc. (CUE)
$23.18-3.34%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $61M
- Avg volume
- 179.9K
- Beta
- 2.47
- P/E (TTM)
- -0.86
- Short % float
- 13.42%
- Days to cover
- 1.9
- SI change
- +13.6%
- 1W
- -16.14%
- 1M
- -27.83%
- 3M
- +7.96%
- YTD
- +129.05%
- vs SPY 1W
- -14.95%
- vs SPY 1M
- -31.15%
- vs SPY 3M
- +5.57%
- vs SPY YTD
- +117.30%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- TNONBUYTenon Medical, Inc.CRISISQ -26$6.31-7.61%
- RGCSELLRegencell Bioscience Holdings LimitedCRISISQ 37$5.29-0.19%
- ANVSBUYAnnovis Bio, Inc.RECOVERYQ 3$1.75-3.85%
- SPRCBUYSciSparc Ltd.RECOVERYQ -24$6.66-0.60%
- CURXBUYCuranex Pharmaceuticals Inc Common StockRECOVERYQ -46$4.63-1.70%
- NNOXSELLNano-X Imaging Ltd.CRISISQ -9$0.86+0.00%
- BCRXBUYBioCryst Pharmaceuticals, Inc.RECOVERYQ 6$9.68+1.36%
- KODSELLKodiak Sciences Inc.CRISISQ 37$37.22-2.90%
- OWLTBUYOwlet, Inc.CRISISQ -21$5.08-2.31%
- TRAWSELLTraws Pharma, Inc.RECOVERYQ -22$0.56+5.66%
- DERMBUYJourney Medical CorporationRECOVERYQ 7$7.91+2.06%
- LFMDSELLLifeMD, Inc.CRISISQ 15$3.14-5.14%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 13
- VALUE
- 6
- GROWTH
- 37
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
GROSS100
OP-262
NET-436
[VALUATION]
P/E TTM-0.86
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B63.63
P/FCF-
EV/EBITDA-0.49
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E133.20
ALTMAN Z-
CURR RATIO1.25
ND/EBITDA-
BETA2.47
